Medicare Enrolled

Dr. Joseph Steeger, MD

Pulmonary Disease · Trenton, NJ
Low-engagement
1542 KUSER RD, Trenton, NJ 08619
6095811400
In practice since 2006 (20 years)
NPI: 1255386595 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Steeger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Steeger? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Steeger

Dr. Joseph Steeger is a pulmonary disease specialist in Trenton, NJ, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Steeger received a total of $4,463 from 36 pharmaceutical and/or device companies across 367 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Steeger is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $4,463 industry payments

Industry Payment Transparency

Open Payments through 2021 ↗
$4,463
Total received (2018-2021)
Avg $1,116/year across 4 years
Top 34% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
367
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,463 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2021
$975
2020
$827
2019
$1,446
2018
$1,215

Payments by company (2021)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$356
AstraZeneca Pharmaceuticals LP
$122
Boehringer Ingelheim Pharmaceuticals, Inc.
$119
GENZYME CORPORATION
$56
Mylan Specialty L.P.
$56
Vanda Pharmaceuticals Inc.
$55
Philips Electronics North America Corporation
$53
Regeneron Healthcare Solutions, Inc.
$28
Takeda Pharmaceuticals U.S.A., Inc.
$25
Teva Pharmaceuticals USA, Inc.
$24
E.R. Squibb & Sons, L.L.C.
$15
Merck Sharp & Dohme Corporation
$14
Janssen Pharmaceuticals, Inc
$14
Grifols USA, LLC
$13
Electromed, Inc.
$13
JAZZ PHARMACEUTICALS INC.
$12
Top 3 companies account for 61.3% of 2021 payments
All-time payments by company (2018-2021) ›
GlaxoSmithKline, LLC.
$1,523
AstraZeneca Pharmaceuticals LP
$625
Boehringer Ingelheim Pharmaceuticals, Inc.
$598
Philips Electronics North America Corporation
$211
Sunovion Pharmaceuticals Inc.
$192
GENZYME CORPORATION
$164
Genentech USA, Inc.
$155
Mylan Specialty L.P.
$106
Actelion Pharmaceuticals US, Inc.
$92
PFIZER INC.
$71
Takeda Pharmaceuticals U.S.A., Inc.
$67
Vanda Pharmaceuticals Inc.
$55
Grifols USA, LLC
$51
JAZZ PHARMACEUTICALS INC.
$49
Electromed, Inc.
$43
Regeneron Healthcare Solutions, Inc.
$42
Circassia Pharmaceuticals Inc
$41
Jazz Pharmaceuticals Inc.
$39
Teva Pharmaceuticals USA, Inc.
$36
La Jolla Pharmaceutical Company
$30
E.R. Squibb & Sons, L.L.C.
$27
Merck Sharp & Dohme Corporation
$26
Novartis Pharmaceuticals Corporation
$26
OptiNose US, Inc.
$25
Harmony Biosciences LLC
$18
Shire North American Group Inc
$15
SANOFI-AVENTIS U.S. LLC
$15
Mallinckrodt Hospital Products Inc.
$14
Mallinckrodt Enterprises LLC
$14
Bayer HealthCare Pharmaceuticals Inc.
$14
Janssen Pharmaceuticals, Inc
$14
BOSTON SCIENTIFIC CORPORATION
$14
Mallinckrodt LLC
$13
Optinose US, Inc.
$13
Advanced Respiratory, Inc
$13
Insmed, Inc.
$12
Top 3 companies account for 61.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · ANORO · ANORO ELLIPTA · ASMANEX · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CINQAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIQUIS · FASENRA · GENERAL BRONCHIAL THERMOPLASTY · GIAPREZA · GLASSIA · HETLIOZ · LONHALA MAGNAIR · NIOX VERO · NUCALA · OFEV · OPSUMIT MACITENTAN · Perforomist · Prolastin-C · Prolastin-C Liquid · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · UTIBRON NEOHALER · Utibron · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · Xhance · Xolair · Xyrem · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Trenton?
Compare pulmonary diseases in the Trenton area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
97
Per 100K population
25.3
County median income
$96,333
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT HAMILTON
2.2 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2021
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Steeger is a pulmonary disease specialist, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Steeger receive payments from pharmaceutical companies?
Yes. Dr. Steeger received a total of $4,463 from 36 companies across 367 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Steeger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Trenton
Browse pulmonary diseases in Trenton ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NJ
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NJ
Which NJ pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →